Who is the CEO of BB Biotech AG?

The CEO of BB Biotech AG is Daniel Koller.

What industry does BB Biotech AG belong to?

BB Biotech AG operates in the Biotechnology industry within the Healthcare sector.

Where is BB Biotech AG headquartered?

BB Biotech AG is headquartered at Seestrasse 16, Kusnacht, 8700, CH.

What is the IPO date of BB Biotech AG?

BB Biotech AG went public on June 29, 2020.

How many employees does BB Biotech AG have?

BB Biotech AG has approximately 10 full-time employees.

BB Biotech AG

BBZA.DE•XETRA

Healthcare

Biotechnology

€34.50

€-1.10(-3.09%)

BB Biotech AG (BBZA.DE) Company Profile & Overview

Explore BB Biotech AG’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

BB Biotech AG (BBZA.DE) Company Profile & Overview

BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.

SectorHealthcare

IndustryBiotechnology

CEODaniel Koller

Contact Information

https://www.bbbiotech.ch/en/bb-biotech

41 44 267 67 00

Seestrasse 16, Kusnacht, 8700

Company Facts

10 Employees

IPO DateJun 29, 2020

CountryCH

Actively Trading

Frequently Asked Questions

;